Netarsudil

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 212 publications

Quantitative prediction of siRNA complexation by ionizable drugs enables their codelivery in nanoparticles.

Quantitative prediction of siRNA complexation by ionizable drugs enables their codelivery in nanoparticles.

Journal: Science advances
Published: June 12, 2026

Persistent Epithelial Defect After Bullae Rupture With Netarsudil.

Persistent Epithelial Defect After Bullae Rupture With Netarsudil.

Journal: Cureus
Published: April 10, 2026

Prognostic factors associated with visual field recovery in non-arteritic anterior ischemic optic neuropathy.

Prognostic factors associated with visual field recovery in non-arteritic anterior ischemic optic neuropathy.

Journal: PloS one
Published: April 07, 2026

Rho-Kinase Inhibitor-A Molecule for Pharmacological Treatment of Decompensated Corneas: Case Series.

Rho-Kinase Inhibitor-A Molecule for Pharmacological Treatment of Decompensated Corneas: Case Series.

Journal: Biomedicines
Published: April 05, 2026

Re-Purposing a Rho-Associated Coiled-Coil Kinase (ROCK) Inhibitor for Alzheimer's Disease.

Re-Purposing a Rho-Associated Coiled-Coil Kinase (ROCK) Inhibitor for Alzheimer's Disease.

Journal: Journal of clinical medicine
Published: March 23, 2026

Repurposing flufenamic acid as a putative PmrB-directed adjuvant to restore colistin activity in Klebsiella pneumoniae.

Repurposing flufenamic acid as a putative PmrB-directed adjuvant to restore colistin activity in Klebsiella pneumoniae.

Journal: Microbiology spectrum
Published: March 17, 2026

Investigating therapeutic response to netarsudil in glaucoma subjects with the ARHGEF12 risk variant.

Investigating therapeutic response to netarsudil in glaucoma subjects with the ARHGEF12 risk variant.

Journal: Frontiers in pharmacology
Published: February 03, 2026

The enantioselective total synthesis of ROCK-inhibitor (S)-Netarsudil (Rhopressa) via asymmetric organocatalysis.

The enantioselective total synthesis of ROCK-inhibitor (S)-Netarsudil (Rhopressa) via asymmetric organocatalysis.

Journal: Organic & biomolecular chemistry
Published: January 21, 2026

Efficacy of Netarsudil in Open and Closed Angle Glaucomas Within the Vietnamese Population: A Single-Center, Retrospective Study.

Efficacy of Netarsudil in Open and Closed Angle Glaucomas Within the Vietnamese Population: A Single-Center, Retrospective Study.

Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: January 19, 2026

Reticular Honeycomb Epithelial Corneal Edema Associated With Netarsudil.

Reticular Honeycomb Epithelial Corneal Edema Associated With Netarsudil.

Journal: JAMA ophthalmology
Published: December 18, 2025

Phase III Prospective Randomised Study of Netarsudil and Concomitant Latanoprost Efficacy and Safety for Primary Open-Angle Glaucoma or Ocular Hypertension in Japan: J-ROCKET-2.

Phase III Prospective Randomised Study of Netarsudil and Concomitant Latanoprost Efficacy and Safety for Primary Open-Angle Glaucoma or Ocular Hypertension in Japan: J-ROCKET-2.

Journal: Advances in therapy
Published: December 08, 2025

Evaluation of cytotoxicity, wound healing, and anti-inflammatory effects of netarsudil on human corneal epithelial cells.

Evaluation of cytotoxicity, wound healing, and anti-inflammatory effects of netarsudil on human corneal epithelial cells.

Journal: Scientific reports
Published: December 05, 2025
Showing 1-12 of 212

Last Updated: 06/30/2026